Dr. Zhou Jianping (周剑平) - Professor of Pulmonology & Interstitial Lung Disease Expert at Renji Hospital, Shanghai Jiao Tong University

Dr. Zhou Jianping (周剑平) - Professor of Pulmonology & Interstitial Lung Disease Expert at Renji Hospital, Shanghai Jiao Tong University

Introduction

Professor Zhou Jianping (周剑平) is a Professor of Pulmonology at Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. Professor Zhou is recognized as one of Shanghai's leading experts in interstitial lung disease (ILD), with particular expertise in idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD, hypersensitivity pneumonitis, and complex pulmonary disorders. His expertise spans the full spectrum of ILD diagnosis and management, with particular distinction in multidisciplinary ILD diagnosis, antifibrotic therapy for IPF, and immunosuppressive therapy for inflammatory ILDs. Renji Hospital's unique strength in rheumatology and connective tissue diseases makes it an ideal center for connective tissue disease-associated ILD. International patients with ILD, pulmonary fibrosis, and complex pulmonary conditions consistently regard Professor Zhou as a premier choice in Shanghai.

Academic Distinctions & Leadership

  • Professor of Pulmonology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
  • Member, Chinese Society of Respiratory Diseases
  • Interstitial Lung Disease Committee Member, Chinese Society of Respiratory Diseases
  • Editorial Board Member, multiple Chinese respiratory medicine journals
  • Recipient, multiple Shanghai municipal science and technology awards
  • Visiting fellow at leading ILD centers internationally

Specializations & Expertise

Idiopathic Interstitial Pneumonias

  • Idiopathic pulmonary fibrosis (IPF) diagnosis and management
  • Antifibrotic therapy (pirfenidone, nintedanib) for IPF
  • Non-specific interstitial pneumonia (NSIP)
  • Cryptogenic organizing pneumonia (COP)
  • Acute interstitial pneumonia (AIP)
  • Respiratory bronchiolitis-ILD
  • Desquamative interstitial pneumonia (DIP)
  • Lymphoid interstitial pneumonia (LIP)

Connective Tissue Disease-Associated ILD

  • Rheumatoid arthritis-associated ILD (RA-ILD)
  • Systemic sclerosis-associated ILD (SSc-ILD)
  • Myositis-associated ILD (antisynthetase syndrome)
  • Sjögren's syndrome-associated ILD
  • Lupus-associated ILD
  • Mixed connective tissue disease-associated ILD
  • IPAF (interstitial pneumonia with autoimmune features)

Other ILD Conditions

  • Hypersensitivity pneumonitis (acute and chronic)
  • Sarcoidosis
  • Drug-induced ILD
  • Radiation-induced ILD
  • Occupational ILD (pneumoconiosis, asbestosis)
  • Lymphangioleiomyomatosis (LAM)
  • Pulmonary alveolar proteinosis (PAP)

ILD Diagnosis

  • High-resolution CT (HRCT) pattern analysis
  • Bronchoalveolar lavage (BAL) for ILD diagnosis
  • Transbronchial lung biopsy
  • Cryobiopsy for ILD diagnosis
  • Surgical lung biopsy coordination
  • Multidisciplinary ILD diagnosis (MDD)
  • Autoimmune serology for CTD-ILD

ILD Treatment

  • Antifibrotic therapy (pirfenidone, nintedanib)
  • Immunosuppressive therapy for inflammatory ILDs
  • Corticosteroid therapy for ILD
  • Mycophenolate mofetil, azathioprine for CTD-ILD
  • Rituximab for refractory CTD-ILD
  • Lung transplant referral for end-stage ILD
  • Pulmonary rehabilitation for ILD
  • Oxygen therapy for ILD

Clinical Excellence & Innovation

  • ILD Multidisciplinary Diagnosis: Expert in multidisciplinary ILD diagnosis (MDD) integrating pulmonology, radiology, rheumatology, and pathology for accurate ILD classification
  • CTD-ILD Expertise: Unique access to Renji Hospital's world-class rheumatology department for comprehensive CTD-ILD management
  • Antifibrotic Therapy: Extensive experience with pirfenidone and nintedanib for IPF, achieving disease stabilization and improved outcomes
  • Cryobiopsy: Advanced transbronchial cryobiopsy for ILD diagnosis, providing larger and better-quality tissue samples than conventional transbronchial biopsy
  • Refractory ILD: Expert in managing refractory CTD-ILD with advanced immunosuppressive regimens including rituximab

Research & Academic Contributions

Professor Zhou is an active researcher with peer-reviewed publications in leading Chinese and international respiratory medicine journals. His research focuses on ILD diagnosis, antifibrotic therapy outcomes, CTD-ILD management, and cryobiopsy techniques.

Hospital Affiliation

Renji Hospital, Shanghai Jiao Tong University School of Medicine
160 Pujian Road, Pudong New Area, Shanghai 200127

Renji Hospital's Pulmonology Department features:

  • Comprehensive ILD diagnosis and management program
  • Unique integration with Renji Hospital's world-class rheumatology department for CTD-ILD
  • Multidisciplinary ILD diagnosis team (MDD)
  • Cryobiopsy program for ILD diagnosis
  • Antifibrotic therapy clinic
  • Pulmonary rehabilitation program
  • International patient services with English-speaking coordinators

Why Choose Professor Zhou Jianping?

  • ILD Specialist: One of Shanghai's foremost experts in interstitial lung disease
  • CTD-ILD Expert: Unique access to Renji Hospital's world-class rheumatology for comprehensive CTD-ILD care
  • Multidisciplinary Diagnosis: Expert MDD for accurate ILD classification
  • Antifibrotic Therapy: Extensive IPF management experience with pirfenidone and nintedanib
  • Cost-Effective Excellence: ILD management costs in Shanghai are typically 60-75% lower than in the US or Europe
  • Proven International Track Record: Trusted by patients from around the world

Conditions Treated

  • Idiopathic pulmonary fibrosis (IPF)
  • Non-specific interstitial pneumonia (NSIP)
  • Cryptogenic organizing pneumonia (COP)
  • RA-ILD, SSc-ILD, myositis-ILD
  • Hypersensitivity pneumonitis
  • Sarcoidosis
  • Drug-induced ILD
  • Pulmonary alveolar proteinosis
  • Lymphangioleiomyomatosis

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking ILD care with Professor Zhou Jianping at Renji Hospital.

Pre-Arrival Support

  • Medical Record Review: Review of your HRCT, PFT, autoimmune serology, BAL, and biopsy reports
  • Virtual Consultation: Video consultation with Professor Zhou's team
  • MDT Review: Arrangement of multidisciplinary ILD diagnosis review
  • Treatment Planning: Personalized ILD management plan
  • Cost Transparency: Detailed cost estimate
  • Visa Assistance: Medical visa guidance and invitation letters
  • Travel Arrangements: Flights, airport pickup, and accommodation near the hospital

During Treatment

  • Professional Medical Interpretation: Experienced pulmonology interpreters at all appointments
  • Hospital Navigation Support: Registration, payment, and hospital navigation assistance
  • 24/7 Support: Round-the-clock assistance for any concerns

Post-Treatment Care

  • Report Translation: Complete translation of all diagnostic and biopsy reports
  • Treatment Summary: Comprehensive ILD summary for your home pulmonologist and rheumatologist
  • Medication Guide: Detailed antifibrotic and immunosuppressive medication instructions
  • Telemedicine Follow-up: Virtual follow-up with Professor Zhou's team
  • Long-term Support: Ongoing assistance after returning home

Schedule Your Consultation

If you or a loved one has IPF, CTD-associated ILD, hypersensitivity pneumonitis, or another interstitial lung disease, Professor Zhou Jianping at Renji Hospital offers world-class ILD expertise at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to request an HRCT and workup review, schedule a virtual consultation, and begin planning your journey to Shanghai for expert ILD care.

Bridging international patients with Shanghai's finest ILD specialists — because your lungs deserve expert care.

0 commenti

Lascia un commento